Locher, C P <br/><br/>
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination.  [electronic resource] 

 -  AIDS research and human retroviruses  Dec 1999 
 - 1685-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0889-2229 
<br/><br/><label>Standard No.: </label>10.1089/088922299309720  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Amino Acid Sequence<br/>Cohort Studies<br/>Consensus Sequence<br/>Enzyme-Linked Immunosorbent Assay<br/>HIV Antibodies--biosynthesis<br/>HIV Envelope Protein gp120--immunology<br/>HIV Infections--immunology<br/>HIV-1--immunology<br/>Humans<br/>Immunization, Secondary<br/>Lymphocyte Activation<br/>Molecular Sequence Data<br/>Neutralization Tests<br/>Sequence Alignment<br/>Sequence Homology, Amino Acid<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Time Factors<br/>Treatment Failure<br/>Vaccines, Synthetic--immunology<br/>Viral Load